Clinical predictors of partial renal response to rituximab therapy in refractory lupus nephritis and associated microvascular retinal disorders (data from real-world clinical practice)
Abstract. The article presents a clinical case of an incomplete renal response to rituximab therapy in a patient of Asian descent with systemic lupus erythematosus (SLE), refractory class IV lupus nephritis, and microvascular retinal abnormalities. The key prognostic factors identified include long-term (more than 18 months) uncontrolled course of SLE, baseline low glomerular filtration rate (38 ml/min), established renal parenchymal fibrosis based on kidney biopsy findings, Asian ethnicity, and interim assessment period (5 months). The pathogenetic relationship between renal and retinal involvement in SLE is discussed, along with possible therapeutic strategies.D.A. Mominova, I.B. Belyaeva, V.I. Mazurov, E.A. Trofimov, V.A. Lila, E.S. Zhugrova
Keywords
References
- Беляева И.Б., Моминова Д.А., Мазуров В.И., Жугрова Е.С. Современный подход к медикаментозной коррекции нарушений микроциркуляции сетчатки у пациентов с системной красной волчанкой. Эффективная фармакотерапия. 2026;22(16):40–46. [Beliaeva IB, Momynova DA, Mazurov VI, Zhugrova ES. Modern approach to drug correction of retinal microcirculation disorders in patients with systemic lupus erythematosus. Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2026;22(16):40–46 (In Russ.)].
EDN: XCYNVT. https://doi.org/10.33978/2307-3586-2026-22-16-40-46
- Койлубаева Г.М., Асеева Е.А., Соловьев С.К., Лила А.М. Особенности системной красной волчанки у пациентов азиатского этноса. Современная ревматология. 2025;19(1):76–82. [Koilubaeva GM, Aseeva EA, Soloviev SK, Lila AM. Characteristics of systemic lupus erythematosus in patients of Asian ethnicity. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2025;19(1):76–82 (In Russ.)].
EDN: VRTQTP. https://doi.org/10.14412/1996-7012-2025-1-76-82
- Wiegley N, Arora S, Norouzi S, Rovin B. A comprehensive and practical approach to the management of lupus nephritis in the current era. Adv Kidney Dis Health. 2024;31(3):234–45.
PMID: 39004463. https://doi.org/10.1053/j.akdh.2023.11.003
- Suzuki E, Yashiro-Furuya M, Temmoku J, Fujita Y, Matsuoka N, Hazama M, et al. Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis. Int J Rheum Dis. 2021;24(12):1500–9.
PMID: 34636151. PMCID: PMC9292939. https://doi.org/10.1111/1756-185X.14228
- Urowitz M, Georgiou ME, Touma Z, Su J, Diaz-Martinez JP, Fu Q, et al. Renal response status to predict long-term renal survival in patients with lupus nephritis: Results from the Toronto Lupus Cohort. Lupus Sci Med. 2024;11(2):e001264.
PMID: 39608814. PMCID: PMC11603717. https://doi.org/10.1136/lupus-2024-001264
- Клинические рекомендации. Системная красная волчанка. Ассоциация ревматологов России. Рубрикатор клинических рекомендаций Минздрава России. 2025. ID: 484_2. Доступ: https://cr.minzdrav.gov.ru/view-cr/484_2 (дата обращения – 15.09.2026). [Clinical guidelines. Systemic lupus erythematosus. Association of Rheumatology of Russia. Rubricator of clinical guidelines of the Ministry of Healthcare Russia. 2025. ID: 484_2. URL: https://cr.minzdrav.gov.ru/view-cr/484_2 (date of access – 15.09.2026) (In Russ.)].
- Furie RA, Rovin BH, Garg JP, Santiago MB, Aroca-Martinez G, Zuta Santillan AE, et al.; REGENCY Trial Investigators. Efficacy and safety of obinutuzumab in active lupus nephritis. N Engl J Med. 2025;392(15):1471–83.
PMID: 39927615. https://doi.org/10.1056/NEJMoa2410965
- Mo S, Li Y, He J, Lin L. Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis. Front Med (Lausanne). 2024;11:1472019.
PMID: 39430591. PMCID: PMC11486751. https://doi.org/10.3389/fmed.2024.1472019
- Basiony AI, Elgouhary SM, Mohamed HE, Zahran ES. Assessment of retinal microvascular changes in patients with systemic lupus erythematosus using optical coherence tomography angiography. Int J Retina Vitreous. 2025;11(1):55.
PMID: 40340989. PMCID: PMC12060311. https://doi.org/10.1186/s40942-025-00677-2
- Serhan HA, Abuawwad MT, Taha MJJ, Hassan AK, Abu-Ismail L, Delsoz M, et al. Purtscher’s and Purtscher-like retinopathy etiology, features, management, and outcomes: A summative systematic review of 168 cases. PLoS ONE. 2024;19(9):e0306473.
PMID: 39240905. PMCID: PMC11379300. https://doi.org/10.1371/journal.pone.0306473
- Ferrigno S, Conigliaro P, Rizza S, Longo S, Nesi C, Carlucci F, et al. Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE. Lupus Sci Med. 2023;10(2):e000977.
PMID: 37852671. PMCID: PMC10603324. https://doi.org/10.1136/lupus-2023-000977
- Wu C, Dai R, Dong F, Wang Q. Purtscher-like retinopathy in systemic lupus erythematosus. Am J Ophthalmol. 2014;158(6):1335–41.e1.
PMID: 25205559. https://doi.org/10.1016/j.ajo.2014.09.001
- Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region. Arthritis Care Res (Hoboken). 2012;64(2):159–68.
PMID: 22052624. https://doi.org/10.1002/acr.20683
- Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–59.
PMID: 31383717. https://doi.org/10.1136/annrheumdis-2018-214819
- Насонов Е.Л., Решетняк Т.М., Соловьев С.К., Попкова Т.В. Системная красная волчанка и антифосфолипидный синдром: вчера, сегодня, завтра. Терапевтический архив. 2023;95(5):365–374. [Nasonov EL, Reshetniak TM, Soloviev SK, Popkova TV. Systemic lupus erythematosus and antiphospholipid syndrome: Yesterday, today, tomorrow. Terapevticheskiy arkhiv = Therapeutic Archive. 2023;95(5):365–374 (In Russ.)].
EDN: WAKJAW. https://doi.org/10.26442/00403660.2023.05.202246
- Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91. PMID: 11838846.
- Marmor MF, Ahn SJ, Ehlers JP, Melles RB, Mieler WF, Sarraf D, Yusuf IH; American Academy of Ophthalmology. Special AAO report: Recommendations on screening for hydroxychloroquine retinopathy (2025 revision).Ophthalmology. 2026;133(4):439–50.
PMID: 41232611. https://doi.org/10.1016/j.ophtha.2025.11.001
- Li F, Liu X, Zhang X, Li M, Liu X. Efficacy and safety of Belimumab, Rituximab and Voclosporin in the treatment of lupus nephritis based on registered clinical trials: A systematic review and network meta-analysis. Lupus. 2025;34(13):1319–33.
PMID: 40911722. https://doi.org/10.1177/09612033251378388
- Zhang T, Wang M, Zhang J, Feng X, Liu Z, Cheng Z. Association between tubulointerstitial CD8+T cells and renal prognosis in lupus nephritis. Int Immunopharmacol. 2021;99:107877.
PMID: 34217995. https://doi.org/10.1016/j.intimp.2021.107877
- Койлубаева Г.М., Асеева Е.А., Соловьев С.К., Лила А.М. Особенности системной красной волчанки у пациентов азиатского этноса. Современная ревматология. 2025;19(1):76–82. [Koilubaeva GM, Aseeva EA, Soloviev SK, Lila AM. Characteristics of systemic lupus erythematosus in patients of Asian ethnicity. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2025;19(1):76–82 (In Russ.)].
EDN: VRTQTP. https://doi.org/10.14412/1996-7012-2025-1-76-82
- Seret G, Hanrotel C, Bendaoud B, Le Meur Y, Renaudineau Y. Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis. Clin Kidney J. 2012;6(1):74–76.
PMID: 27818754. PMCID: PMC5094396. https://doi.org/10.1093/ckj/sfs162
- Serhan HA, Abuawwad MT, Taha MJJ, Hassan AK, Abu-Ismail L, Delsoz M, et al. Purtscher’s and Purtscher-like retinopathy etiology, features, management, and outcomes: A summative systematic review of 168 cases. PLoS ONE. 2024;19(9):e0306473.
PMID: 39240905. PMCID: PMC11379300. https://doi.org/10.1371/journal.pone.0306473
- De Vriese AS, Sethi S, Fervenza FC. Lupus nephritis: Redefining the treatment goals. Kidney Int. 2025;107(2):198–211.
PMID: 39571903. https://doi.org/10.1016/j.kint.2024.10.028
- Chazaro Rocha EF, Zavala Miranda MF, Sanchez-Mejia DE, Otamendi ER, Mejia-Vilet JM. Efficacy of rituximab in a frequently relapsing lupus nephritis cohort: Prior response shapes current flare outcomes. J Am Soc Nephrol. 2025;36(10S).
https://doi.org/10.1681/ASN.20255aky2ap8
- Попкова Т.В., Панафидина Т.А., Лила А.М. Методические рекомендации (проект). Системная красная волчанка: диагностика, лечение, мониторинг (сокращенная версия). Терапия. 2025;11(1):8–15. [Popkova TV, Panafidina TA, Lila AM. Methodological recommendations (draft). Systemic lupus erythematosus: Diagnosis, treatment, monitoring (short version). Terapiya = Therapy. 2025;11(1):8–15 (In Russ.)].
EDN: CSBCRI. https://doi.org/10.18565/therapy.2025.1.8-1
About the Authors
Dilnoza A. Mominova, MD, postgraduate applicant of the Department of therapy and rheumatology named after E.E. Eichwald, I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russian Federation; rheumatologist at Dr. Maksudova Clinic, Tashkent, Republic of Uzbekistan.ORCID: https://orcid.org/0009-0007-8608-8830
Irina B. Belyaeva, MD, Dr. Sci. (Medicine), professor, professor of the Department of therapy and rheumatology named after E.E. Eichwald, I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russian Federation.
Е-mail: belib@mail.ru
ORCID: https://orcid.org/0000-0001-5261-6614
Vadim I. Mazurov, MD, Dr. Sci. (Medicine), professor, academician of RAS, director of the Research Institute of Rheumatology, I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russian Federation.
ORCID: https://orcid.org/0000-0002-0797-2051
Evgeny A. Trofimov, MD, Dr. Sci. (Medicine), professor, head of the Department of therapy and rheumatology named after E.E. Eichwald, I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russian Federation, Saint Petersburg, Russian Federation.
ORCID: https://orcid.org/0000-0003-3236-4485
Victoria A. Lila, MD, PhD (Medicine), associate professor, associate professor of the Department of therapy and rheumatology named after E.E. Eichwald, I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russian Federation.
ORCID: https://orcid.org/0000-0001-5006-3358
Elena S. Zhugrova, MD, PhD (Medicine), associate professor, associate professor of the Department of therapy and rheumatology named after E.E. Eichwald, I.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russian Federation.
ORCID: https://orcid.org/0000-0002-8622-5205



